Skip to main content

Patient Reported Fatigue Following Chemotherapy among Adults with Breast Cancer

CBE ID
3720
Endorsed
New or Maintenance
New
Is Under Review
No
E&M Cycle Comments

Effective March 27, 2023, the National Quality Forum (NQF) is no longer the consensus-based entity (CBE) funded through the Centers for Medicare & Medicaid Services (CMS) National Consensus Development and Strategic Planning for Health Care Quality Measurement Contract. Battelle has been selected to oversee the endorsement & maintenance (E&M) of clinical quality and cost/resource use measures. Since the Fall 2022 cycle launched at NQF, measures submitted to this E&M cycle continued along the prior E&M protocols that were in place at time of the Fall 2022 “Intent to Submit.” Battelle took over the E&M work for the Fall 2022 cycle after developers and/or stewards submitted their full measure information to NQF, which for CBE #3720, the most recent measure specifications can be found here: https://p4qm.org/sites/default/files/2024-02/3720.zip

Battelle took over the E&M work beginning with the public comment period to close the E&M committees for the post-comment meeting, convening the CSAC to render a final endorsement decision, and executing the appeals period.

 

Measure Description
The PRO-PM assesses fatigue among adult women with breast cancer entering survivorship after completion of chemotherapy administered with curative intent. Fatigue is assessed using the PROMIS Fatigue 4a scale administered at baseline (prior to chemotherapy) and at follow-up (about three months following completion of chemotherapy). The measure is risk-adjusted.
  • Measure Type
    Patient-reported Outcome-Based Performance Measure (PRO-PM)
    MAT output not attached
    Attached
    Data dictionary not attached
    No
    Numerator

    The PRO-PM numerator is the group-level PROMIS Fatigue score at the follow-up survey.

    Denominator

    Adult patients with stages I-III female breast cancer receiving an initial chemotherapy regimen within the measurement window.

    All information required to stratify the measure results
    Off
    All information required to stratify the measure results
    Off
  • Risk adjustment approach
    Off
    Risk adjustment approach
    Off
    Conceptual model for risk adjustment
    Off
    Conceptual model for risk adjustment
    Off
  • Most Recent Endorsement Activity
    Endorsed Patient Experience and Function Fall 2022
    Initial Endorsement
    Next Planned Maintenance Review
    Fall 2027
    Endorsement Status
    Endorsed
    Last Updated
  • Do you have a secondary measure developer point of contact?
    Off
    Measure Developer Secondary Point Of Contact

    United States

    The measure developer is NOT the same as measure steward
    Off
    Steward
    Purchaser Business Group on Health
    Steward Organization Email
    [email protected]
    Steward Address

    United States

  • Detailed Measure Specifications
    No
    Logic Model
    Off
    Impact and Gap
    No
    Feasibility assessment methodology and results
    No
    Address health equity
    No
    Measure’s use or intended use
    No
    508 Compliance
    Off
    If no, attest that all information will be provided in other fields in the submission.
    Off